Home  »  Finance   »  Larimar Therapeutics Inc (NASDAQ: LRMR): What Do W...

Larimar Therapeutics Inc (NASDAQ: LRMR): What Do Wall Street Experts Say?

Larimar Therapeutics Inc (NASDAQ:LRMR) price is hovering lower on Monday, February 12, dropping -6.12% below its previous close.

A look at today’s price movement shows that the recent level at last check reads $7.76. The company’s 5Y monthly beta was ticking 0.47. Taking into account the 52-week price action we note that the stock hit a 52-week high of $7.79 and 52-week low of $2.18. The stock added 58.03% on its value in the past month.

#1 Small-Cap Uranium Stock for Ultra-Fast Gains in 2024

We've uncovered THE ONE small-cap uranium stock that has unearthed a near-surface, high-grade uranium discovery in the Saudi Arabia of Uranium — Canada's prolific Athabasca Basin. Best of all, this small-cap uranium stock is currently flying just below Wall Street's radar… giving you the early-entry opportunity around US$0.30 per share. But that won't last long. Drills are turning right now with results set to be released to the market very, very soon.

Learn all about it in this brand new FREE online report.
Sponsored

Larimar Therapeutics Inc, which has a market valuation of $319.88 million, is expected to release its quarterly earnings report Mar 12, 2024 – Mar 18, 2024. Analysts tracking LRMR have forecast the quarterly EPS to shrink by -0.25 per share this quarter, while the same analysts predict the annual EPS to hit -$0.75 for the year 2024 and up to -$1.05 for 2024. In this case, analysts estimate an annual EPS growth of 45.30% for the year and -40.00% for the next year.

Revisions to the company’s EPS highlights a short term direction of a stock’s price movement, which in the last 7 days came up with no upward and no downward reviews. On the technical perspective front, indicators give LRMR a short term outlook of 100% Buy on average. Looking at the stock’s medium term indicators we note that it is averaging as a 100% Buy, while an average of long term indicators are currently assigning the stock as 100% Buy.

The overview shows that LRMR’s price is at present 38.30% off the SMA20 and 58.14% from the SMA50. The Relative Strength Index (RSI) metric on the 14-day timeframe is pointing at 72.25, with weekly volatility standing at 12.06%. The indicator jumps to 9.25% when calculated based on the past 30 days. Larimar Therapeutics Inc (NASDAQ:LRMR)’s beta value is holding at 0.77, while the average true range (ATR) indicator is currently reading 0.59.

An analysis of the Larimar Therapeutics Inc (NASDAQ:LRMR) stock in terms of its daily trading volume indicates that the 3-month average is 28.34. However, this figure increases on the past 10-day timeline to an average of 0.32 million.

Current records show that the company has 43.27M in outstanding shares. The insiders’ percentage holdings are 42.01% of outstanding shares while the percentage share held by institutions stands at 48.96%. The stats also highlight that short interest as of Jan 31, 2024, stood at 0.34 million shares, which puts the short ratio at the time at 1.52. From this we can glean that short interest is 0.77% of company’s current outstanding shares. Notably, we see that shares short in January fall slightly given the previous month’s figure stood at 0.39 million. But the 60.11% upside, the stock’s price has registered year-to-date as of today’s value, will likely reignite investor interest given the prospect of it rallying even higher.